Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Lab open days in September when the works due to complete, maybe there is an announcement prior to the day.
Onwards and upwards revenue wise from here on in.
A few guessed this news whats could be the next ?
Small amounts being talked about these days shares holdings wise.
Be funny if Stella popped up with a buying rns eh Metom I’d laugh my c*** off pal.
I Doubt it but something has to and will change soon.
I’m
Surprised Pork’s is not CEO of a multinational the i do he’s giving out he’s that knowledgeable about running a plc.
Whack your CV on here fella let’s have a giggle… Shoulda woulda coulda the worlds full of them.
Freddie probably achieved more in a weeks work than you’ll do in life.
It’s p*** easy to prove me wrong Porky Lie.
Postman Pork’s or the prof it’s a simple answer
Dr Adam Hargreaves (PathCelerate Limited)LinkedIn
Dr. Adam Hargreaves is the founder of PathCelerate Limited, a contract research drug efficacy and safety company. Spanning a 20 year career, he previously worked for AstraZeneca, and has interests and skills in preclinical and translational small molecule, biologic, and RNA-based pharmaceuticals. PathCelerate has provided preclinical and clinical drug discovery and development assistance to the majority of the global top 20 pharmaceutical companies, in addition to a wide and diverse range of small- and medium-sized biotechnology and medical device firms; assisting in the generation of numerous Investigational New Drug and Clinical Trial Application submissions.
Adam is a Fellow of the Royal College of Pathologists, and is a board-certified Diplomate of the American College of Veterinary Pathology. He has a PhD in oncology medicine safety and is a visiting Professor at the University of Surrey, where he lectures in pharmaceutical toxicology.